메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Kittipak Jenghua (Division of Social and Administrative Pharmacy Department of Pharmaceutical Care School of Pharmaceutical Sciences University of Phayao Phayao Thailand) Kanchira Wutthi (Division of Social and Administrative Pharmacy Department of Pharmaceutical Care School of Pharmaceutical Sciences University of Phayao Phayao Thailand) Chanisorn Wannakrachang (Division of Social and Administrative Pharmacy Department of Pharmaceutical Care School of Pharmaceutical Sciences University of Phayao Phayao Thailand) Sitanan Chathongyos (Division of Social and Administrative Pharmacy Department of Pharmaceutical Care School of Pharmaceutical Sciences University of Phayao Phayao Thailand) Panadda Ngamsom (Pharmacy Department Chiangkham Hospital Phayao Thailand)
저널정보
대한노인병학회 Annals of geriatric medicine and research Annals of geriatric medicine and research Vol.27 No.2
발행연도
2023.6
수록면
116 - 125 (10page)
DOI
10.4235/agmr.23.0036

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: No comprehensive assessment of the quality of medications used in older outpatients has been conducted in Thailand. This study aimed to ascertain the prevalence of and factors contributing to older outpatients' use of potentially inappropriate medications (PIMs). Methods: This cross-sectional study retrospectively assessed the prescriptions of older (≥60 years) outpatients at a secondary-care hospital. For PIM identification, the 2019 American Geriatric Society (AGS) Beers criteria were applied, considering all five PIM categories: PIM category I (medications that are potentially inappropriate in most older adults), II (disease-/syndrome-exacerbating drugs), III (medications that should be used with caution), IV (clinically important drug–drug interactions), and V (medications that should be avoided or have their dosage reduced based on renal function). Results: This study included 22,099 patients (mean age, 68.86±7.64 years). Nearly three-fourths of patients were prescribed PIMs, with 68.90%, 7.68%, 44.23%, 15.66%, and 3.05%, respectively, receiving category I–V medications. The positive factors associated with PIM use included female sex (odds ratio [OR]=1.08; 95% confidence interval [CI], 1.01–1.16), age ≥75 years (OR=1.10; 95% CI, 1.01–1.21), polypharmacy (OR=10.21; 95% CI, 9.31–11.21), ≥3 diagnostic categories (OR=2.31; 95% CI, 2.14–2.50), and ≥3 chronic morbidities (OR=1.46; 95% CI, 1.26–1.68). The negative factor associated with PIM use was a comorbidity score of ≥1 (OR=0.78; 95% CI, 0.71–0.86). Conclusion: PIM use among older outpatients remains highly prevalent in clinical practice. The results of this study identified polypharmacy as the strongest factor affecting PIM use.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0